Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR
The tetravalent dengue vaccine strain (TV003/TV005) originally developed by the National Institutes of Health, the U.S., has shown promising results in preclinical and clinical trials worldwide. Representational File Image | Photo Credit: The Hindu Following an announcement by the Indian Council of Medical Research (ICMR) and Panacea Biotec Limited to initiate third phase trials, about … Read more